• 제목/요약/키워드: 5-Year survival rate

검색결과 1,255건 처리시간 0.03초

Survival Rate of Breast Cancer Patients In Malaysia: A Population-based Study

  • Abdullah, Nor Aini;Mahiyuddin, Wan Rozita Wan;Muhammad, Nor Asiah;Ali, Zainudin Mohamad;Ibrahim, Lailanor;Tamim, Nor Saleha Ibrahim;Mustafa, Amal Nasir;Kamaluddin, Muhammad Amir
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권8호
    • /
    • pp.4591-4594
    • /
    • 2013
  • Breast cancer is the most common cancer among Malaysian women. Other than hospital-based results, there are no documented population-based survival rates of Malaysian women for breast cancers. This populationbased retrospective cohort study was therefore conducted. Data were obtained from Health Informatics Centre, Ministry of Health Malaysia, National Cancer Registry and National Registration Department for the period from $1^{st}$ January 2000 to $31^{st}$ December 2005. Cases were captured by ICD-10 and linked to death certificates to identify the status. Only complete data were analysed. Survival time was calculated from the estimated date of diagnosis to the date of death or date of loss to follow-up. Observed survival rates were estimated by Kaplan-Meier method using SPSS Statistical Software version 17. A total of 10,230 complete data sets were analysed. The mean age at diagnosis was 50.6 years old. The overall 5-year survival rate was 49% with median survival time of 68.1 months. Indian women had a higher survival rate of 54% compared to Chinese women (49%) and Malays (45%). The overall 5-year survival rate of breast cancer patient among Malaysian women was still low for the cohort of 2000 to 2005 as compared to survival rates in developed nations. Therefore, it is necessary to enhance the strategies for early detection and intervention.

The Survival Rate of Korean Patients with COPD with or without Acute Exacerbations

  • Uh, Soo-Taek;Lee, Ji-Yeon;Koo, So-Mi;Kim, Yang-Ki;Kim, Ki-Up;Park, Jong-Sook;Park, Sung-Woo;Jang, An-Soo;Kim, Do-Jin;Choi, Jae-Sung;Na, Joo-Ok;Suh, Ki-Hyun;Kim, Yong-Hoon;Park, Choon-Sik
    • Tuberculosis and Respiratory Diseases
    • /
    • 제70권6호
    • /
    • pp.474-481
    • /
    • 2011
  • Background: Chronic obstructive pulmonary disease (COPD) is characterized by air low limitation, which is one of the leading causes of mortality worldwide. There have been many studies on survival rates in the world literature, but there have been few reports regarding the survival rate in Korean patients with COPD. Acute exacerbation is regarded as a risk factor for mortality in patients with COPD. The purpose of this study was to investigate the survival rate and the effect of acute exacerbations on the survival rate of Korean patients with COPD. Methods: A total of 502 COPD patients who were diagnosed on the basis of history and lung function tests were enrolled in this study. The frequency of acute exacerbations, body mass index (BMI), C-reactive protein (CRP) and pulmonary hypertension were analyzed. Results: The 3- and 5-year survival rates were 98% and 83%, respectively. The median survival time was 78 months. The median survival time was 55 months in 322 patients with one or more acute exacerbations. The 3- and 5-year survival rates were significantly lower in the 322 patients with one or more acute exacerbations than in those without any. The mortality rate was significantly higher in patients with CRP>3 mg/L than in those with CRP ${\leq}3$ mg/L (p<0.005); it was significantly higher in patients with pulmonary hypertension than in those without it (p<0.01). Conclusion: Because the 5-year survival rate is 83% in Korean patients with COPD, the management of stable patients with COPD should focus on the prevention of acute exacerbations.

위암 환자의 담즙 CEA 농도와 장기 생존율 및 간전이와의 연관성 (Carcinoembryonic Antigen (CEA) in the Gallbladder Bile (b-CEA) of Gastric Carcinoma Patients with Long-term Follow up)

  • 백상현;김현구;강민수;신연명;최경현
    • Journal of Gastric Cancer
    • /
    • 제4권1호
    • /
    • pp.1-6
    • /
    • 2004
  • Purpose: Despite numorous reports on the relationship between the level of carcinoembryonic antigen (CEA) in gall bladder bile and liver metastasis in colorectal cancer, no similar studies have been carried out for gastric carcinomas. We, therefore, undertook the present study to establish the relationship between the gall bladder bile CEA and liver metastasis as well as the post-operative survival rate in gastric carcinoma patients with curative resections. Materials and Methods: In 373 gastric cancer patients (252 males, 121 females, age $21\∼76$ years) operated on at Kosin University Hospital between 1989 1996, the CEA concentration in the gall bladder bile was determined during the operation and the value was related to the rates of post-operative survival and liver metastasis during follow-up period. Results: The overall rate of patient survival decreased gradually with increase in TNM stage. The 13-year postoperative survival rates for stages Ia, Ib, II, IIIa, and IIIb were $95.7\%,\;92.5\%,\;79.9\%,\;50.9\%,\;and\;43.3\$, respectively, and the 10-year survival rate for stage IV was $22.6\%$. The patients with a high ($\geq$10 ng/ml) biliary CEA showed a significantly lower rate of survival than those with a low (<10 ng/ml) biliary CEA. The 13-year cumulative survival rate was $55.4\%$ for the high CEA group and $76.5\%$ for the low CEA group (P<0.01). Also, the patients with a high biliary CEA showed a significantly higher rate ($11.5\%$) of liver metastasis than those with a low biliary CEA ($1.9\%$) (P<0.000). In patients with TNM stages (I and II), the CEA level did not affect the post-operative survival rates ($95.4\%\;and87.7\%$ in the high and low CEA groups, P>0.10), but in those with high TNM stages (III and IV), the survival rate was significantly lower in the high CEA group ($25.9\%$) than in the low CEA group ($57.8\%$) (P<0.05). Conclusion: These result suggest that the gall bladder bile CEA level obtained in an advanced-staged gastric cancer operation may be used in predicting the post-operational survival rate and in sorting out patients with a high risk for cancer recurrence, especially in the liver area.

  • PDF

Ovarian Transposition for Stage Ib Squamous Cell Cervical Cancer - Lack of Effects on Survival Rates?

  • Turan, A. Taner;Keskin, H. Levent;Dundar, Betul;Gundogdu, Burcu;Ozgul, Nejat;Boran, Nurettin;Tulunay, Gokhan;Kose, M. Faruk
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권1호
    • /
    • pp.133-137
    • /
    • 2013
  • Background: To investigate the impact of ovarian transposition (OT) on survival rates of the patients with stage Ib squamous cell cervical cancer. Materials and Methods: Ninety-two subjects who underwent a radical hysterectomy including oophorectomy were evaluated. For nineteen (20.7%), OT was performed. Patients were divided into two groups, OT versus oophorectomy alone. The primary end-point of this study was to investigate the impact of OT on tumor recurrence rate and time, 5-year disease-free survival (DFS) and overall survival (OS). These comparisons were performed for subgroups including patients who received radiotherapy versus who did not. Statistical analyses were conducted using the Chi-square test, T-test and Mann-Whitney test. OS was examined using the Kaplan-Meier method. $P{\leq}0.05$ was considered to be statistically significant. Results: The median follow-up period was 89 months for OT and 81 months for the oophorectomy group (p>0.05). Both groups experienced similar recurrence rates (31.6% vs. 26.4%, p=0.181). The median duration from surgery to recurrence, and surgery to death were also similar between the groups (p>0.05). The 5-year DFS and OS rates were both 68.4% for the OT group, and 73.6% and 77.8% for the oophorectomy group (p=0.457 and p=0.307, respectively). While the 5-year DFS rate was not statistically significant between the OT and oophorectomy groups who did not receive radiotherapy (p=0.148), the 5-year OS rate was significantly higher in the oophorectomy group (95.4% vs 66.7%, respectively) without radiotherapy (p=0.05). The 5-year DFS and OS rates were statistically similar between the groups who received adjuvant radiotherapy (p>0.05). Conclusions: Ovarian transposition has not significantly negative effect on the survival rates when adjuvant radiotherapy will be applied, while 5-year OS may be less in OT group if radiotherapy is not mandatory.

SLA surface를 가진 taper straight designed implant의 방사선학적 평가와 생존율: 1년 추적 관찰을 통한 후향적 연구 (Radiologic evaluation and survival rate of taper-straight designed implant with SLA surface: A 1-year follow-up retrospective study)

  • 김지은;김예슬;김옥수
    • 대한치과보철학회지
    • /
    • 제59권4호
    • /
    • pp.405-414
    • /
    • 2021
  • 목적: 이번 연구는 최근 시판되고 있는 국내산 taper straight 타입의 SLA surface를 가진 임플란트의 변연골 흡수도와 생존율을 평가하여 임상적 유용성을 알아보기 위해 시행하였다. 대상 및 방법: 전남대학교 치과병원 치주과에서 2016년 8월부터 2019년 12월까지 KISPLANT®가 식립된 성인남녀 83명의 125개의 임플란트 중 포함 기준을 충족시키는 19명의 40개의 임플란트를 1년 동안의 관찰 대상으로 하였다. 처음과 1년 후의 치근단 방사선 사진에서 변연골 수준을 측정하고, 이를 이용하여 임플란트 생존율과 성공률을 분석하였다. 또한 치주염 심도, SPT, 식립 부위, 치아 발거 이유, 즉시 식립 여부, 전신질환에 따라 변연골 흡수도에 유의한 차이가 있는지를 확인하기 위해 t-test를 수행하였다. 결과: 근심측 변연골 흡수도는 0.74 ± 1.07 mm, 원심측 변연골 흡수도는 0.53 ± 1.04 mm로 나타났다. 1년 동안 40개의 임플란트 중 3개의 임플란트에서 2 mm 이상의 변연골 흡수가 일어나 임플란트 성공률은 92.5%이고 생존율은 100%이었다. t-test를 수행한 결과 근심측 변연골 흡수도와 식립 부위에서 유의한 차이가 있었고 나머지 요인에서는 유의한 차이가 없었다. 결론: 이번 연구에서 변연골 흡수도와 성공률, 생존율을 평가해 본 결과 임플란트 식립 1년 후 높은 생존율과 성공률을 보였고 낮은 변연골 흡수도를 보여 taper straight 타입의 SLA surface를 가진 임플란트는 우수한 임상 결과를 보였다.

두경부에 국한된 Stage I, II, Non-Hodgkin's Lymphoma의 방사선치료 (Radiotherapy of Stage I and B localized Bead and Heck Non-Hodgkin's Lymphoma)

  • 오원용;서창옥;김귀언;김병수
    • Radiation Oncology Journal
    • /
    • 제2권1호
    • /
    • pp.49-58
    • /
    • 1984
  • 53 patients of previously untreated Stage I&II Non-Hodgkin's Lymphoma in head and neck treated with irradiation at Yonsei Cancer Center from January, 1970 to December, 1978 were retrospectively analysed. 5 year survival rate and 5 year disease free survival rate were $51.5\%\;and\;42\%$. Local control rate by irradiation was $92.4\%$ with mainly $4,000\~6,000$ rads. 21 patients suffered relapses after radiotherapy, 4 cases recurred within irradiated area, 4 cases at contiguous site of irradiation field, and 13 cases recurred at distant area, more commonly below diaphragm. Most cases relapsed within 1 year 6 months after treatment. Optimum irradiation field for head and neck localized lymphoma, prognostic factors ana usefulness of chemotherapy are also discussed.

  • PDF

Long Term Survival of Patients with Unsuspected N2 Disease in Non-Small Cell Lung Cancer

  • Lee, Deok Heon;Kim, Jae Bum;Keum, Dong Yoon;Hwang, Ilseon;Park, Chang Kwon
    • Journal of Chest Surgery
    • /
    • 제46권1호
    • /
    • pp.49-55
    • /
    • 2013
  • Background: The aim of this study was to determine the survival rate of patients with non-small cell lung cancer (NSCLC) who were preoperatively diagnosed with a negative N2 lymph node, but postoperatively confirmed as a positive N2 node based on a pathological evaluation. Materials and Methods: The hospital records of 248 patients from 1994 to 2009 with resected primary NSCLC who were preoperatively diagnosed with negative N2 lymph node, were retrospectively reviewed. Of these, after surgery, there were 148 (59.7%) patients with pathological N0, 54 (21.8%) with pathological N1 and 46 (18.5%) with pathological N2. Results: The median follow-up period was 24 months (range, 1 to 132 months). The 5-year disease free survival rates were 60% in pN0, 44% in pN1, and 29% in pN2. The 5-year overall survival rates were 63.1% in pN0, 51.9% in pN1, and 33.5% in pN2. There were no statistically significant differences between pN1 and pN2 (p=0.326 and p=0.106, respectively). Thirty-three (71.7%) of the 46 pN2 patients had single-zone metastasis, and 13 patients (28.3%) had multiple-zone metastases over the two nodal zone metastasis. There were no statistical differences in the 5-year disease free survival rate and the 5-year overall survival rates between the two groups. Conclusion: The 5-year disease free survival and the overall survival rate of the patients with unsuspected N2 disease were statistically similar with that of the patients with pathological N1 disease. There was no statistically significant difference between the patients with a single-zone metastasis and a multiple zone metastasis.

3년산 북방전복, Haliotis discus hannai의 해상가두리 내 먹이공급비율에 따른 성장 및 생존율 (The Effect of Growth and Survival Rate on Feeding Rate of 3-year-old Abalone, Haliotis discus hannai rearing in Net Cage Culture)

  • 김병학;박정준;손맹현;김태익;이시우
    • 한국패류학회지
    • /
    • 제32권2호
    • /
    • pp.103-109
    • /
    • 2016
  • 본 연구는 3년산 북방전복의 해상가두리의 먹이공급비율에 따른 성장 및 생존율을 조사하여, 미역과 다시마등의 천연먹이의 적정 공급율을 제안하여 북방전복 성패의 생산성 향상을 유도하고자 실시하였다. 먹이공급율은 실험전복 어체중량을 기준으로 일간공급율 (daily feeding rate, DFR) 5, 10, 15, 20% (5 DFR, 10 DFR, 15 DFR, 20 DFR) 를 설정하여, 해상가두리에서 2반복으로 13개월간 실시하였다. 해상가두리에서 사육한 전복 (최초 수용 시 평균각장 $73.77{\pm}11.27mm$) 성장에서 각장과 각폭의 성장율 (growth rate, GR), 일간성장율 (daily growth rate, DGR) 및 특수생장율 (specific growth rate, SGR) 과 체중의 증중률 (weight gain, WG), 일간증중률 (daily weight gain, DWG) 및 특수증중률 (specific weight gain, SWG), 그리고 생존율에서 5 DFR이 유의적으로 높았다 (P < 0.05). 생존율은 모든 실험구가 유의적 차이가 없었으며, 30%이하로 나타났다. 따라서 3년산 북방전복을 해상가두리에서 사육 시 미역, 다시마 등의 생먹이의 일간 공급율은 어체중량의 5-10%에서 공급되는 것이 성장에 유리하지만, 생존율을 향상 시킬 수 있는 다각적 검토가 필요하다.

원발성위장관임파종의 방사선치료 (Localized Primary Gastrointestinal Lymphomas)

  • 서창옥;김귀언;박창윤;김병수
    • Radiation Oncology Journal
    • /
    • 제2권1호
    • /
    • pp.93-100
    • /
    • 1984
  • Among 238 patients with Non-Hodgkin's lymphoma received radiotherapy at Yonsei Cancer center, Yonsei University Medical College, from 1970 to 1981, 30 patients presented with localized(Stage I&II ) gastrointestinal lymphomas. Retrospective analysis of these 30 cases in an attempt to evaluate the influence of various prognostic factors and the effectiveness of therapy is presented. Overall 5 year survival rate of 30 cases of primary gastrointestinal lymphoma was $48\%$. Bulk of residual disease after initial surgery and stage were significant prognostic factors. Stage I with small residual disease treated with post-op irradiation achieved $100\%$ 5 year survival rate. So above group is considered curable with surgery and post-op irradiation. $80\%$ of Stage II with large residual disease were died with intra-abdominal local tumor control failure. Stage II with small residual disease showed $31.5\%$ 5 year survival rate. Non of them died with local failure. So, we suggest that complete surgical resection of tumor mass should be attempted initially in the management of localized gastrointestinal lypmhomas and systemic chemotherapy is needed in addition to post-op irradiation in the cases of Stage II and large residual disease after initial surgery.

  • PDF

Estimation of the Cure Rate in Iranian Breast Cancer Patients

  • Rahimzadeh, Mitra;Baghestani, Ahmad Reza;Gohari, Mahmood Reza;Pourhoseingholi, Mohamad Amin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권12호
    • /
    • pp.4839-4842
    • /
    • 2014
  • Background: Although the Cox's proportional hazard model is the popular approach for survival analysis to investigate significant risk factors of cancer patient survival, it is not appropriate in the case of log-term disease free survival. Recently, cure rate models have been introduced to distinguish between clinical determinants of cure and variables associated with the time to event of interest. The aim of this study was to use a cure rate model to determine the clinical associated factors for cure rates of patients with breast cancer (BC). Materials and Methods: This prospective cohort study covered 305 patients with BC, admitted at Shahid Faiazbakhsh Hospital, Tehran, during 2006 to 2008 and followed until April 2012. Cases of patient death were confirmed by telephone contact. For data analysis, a non-mixed cure rate model with Poisson distribution and negative binomial distribution were employed. All analyses were carried out using a developed Macro in WinBugs. Deviance information criteria (DIC) were employed to find the best model. Results: The overall 1-year, 3-year and 5-year relative survival rates were 97%, 89% and 74%. Metastasis and stage of BC were the significant factors, but age was significant only in negative binomial model. The DIC also showed that the negative binomial model had a better fit. Conclusions: This study indicated that, metastasis and stage of BC were identified as the clinical criteria for cure rates. There are limited studies on BC survival which employed these cure rate models to identify the clinical factors associated with cure. These models are better than Cox, in the case of long-term survival.